Probably not. That's an average-to-low price for a monoclonal antibody in the US, and many people with chronic (non-cancer) conditions pay that price every few

Probably not. That's an average-to-low price for a monoclonal antibody in the US, and many people with chronic (non-cancer) conditions pay that price every few weeks to remain healthy under something like a health-as-a-subscription model.